UK Biobank to Use RTS Sample-Processing Systems | GenomeWeb

NEW YORK (GenomeWeb News) – RTS Life Science will provide the UK Biobank with four systems for processing saliva and blood samples, the company said today.

UK Biobank, which officially launched in late July, will use four of the company’s Automated Sample Processor 800 systems to process participant samples.

The company said that the new instruments will allow the project to process up to 800 samples per day.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.